img

Global Sustained Release Ocular Drug Delivery Systems Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sustained Release Ocular Drug Delivery Systems Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Sustained Release Ocular Drug Delivery Systems report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sustained Release Ocular Drug Delivery Systems market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cataract and Glaucoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sustained Release Ocular Drug Delivery Systems industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sustained Release Ocular Drug Delivery Systems key manufacturers include pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics and GrayBug, etc. pSivida, Allergan, Icon Bioscience are top 3 players and held % sales share in total in 2022.
Sustained Release Ocular Drug Delivery Systems can be divided into Liposome, Microcapsules/Nanocapsules, Microspheres/Nanosptheres and Implants, etc. Liposome is the mainstream product in the market, accounting for % sales share globally in 2022.
Sustained Release Ocular Drug Delivery Systems is widely used in various fields, such as Cataract, Glaucoma, Corneal Transplantation and Others, etc. Cataract provides greatest supports to the Sustained Release Ocular Drug Delivery Systems industry development. In 2022, global % sales of Sustained Release Ocular Drug Delivery Systems went into Cataract filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sustained Release Ocular Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
Segment by Type
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants

Segment by Application


Cataract
Glaucoma
Corneal Transplantation
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Sustained Release Ocular Drug Delivery Systems market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sustained Release Ocular Drug Delivery Systems, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sustained Release Ocular Drug Delivery Systems industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sustained Release Ocular Drug Delivery Systems in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sustained Release Ocular Drug Delivery Systems introduction, etc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sustained Release Ocular Drug Delivery Systems market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Sustained Release Ocular Drug Delivery Systems Product Overview
1.2 Sustained Release Ocular Drug Delivery Systems Market Segment by Type
1.2.1 Liposome
1.2.2 Microcapsules/Nanocapsules
1.2.3 Microspheres/Nanosptheres
1.2.4 Implants
1.3 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Overview by Type (2018-2034)
1.3.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size Review by Type (2018-2024)
1.3.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2024)
1.4.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2024)
2 Global Sustained Release Ocular Drug Delivery Systems Market Competition by Company
2.1 Global Top Players by Sustained Release Ocular Drug Delivery Systems Sales (2018-2024)
2.2 Global Top Players by Sustained Release Ocular Drug Delivery Systems Revenue (2018-2024)
2.3 Global Top Players by Sustained Release Ocular Drug Delivery Systems Price (2018-2024)
2.4 Global Top Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Sustained Release Ocular Drug Delivery Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
2.8 Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sustained Release Ocular Drug Delivery Systems Status and Outlook by Region
3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size by Region
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2018-2024)
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2018-2024)
3.2.3 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Region
3.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2024-2034)
3.3.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2024-2034)
3.3.3 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Sustained Release Ocular Drug Delivery Systems by Application
4.1 Sustained Release Ocular Drug Delivery Systems Market Segment by Application
4.1.1 Cataract
4.1.2 Glaucoma
4.1.3 Corneal Transplantation
4.1.4 Others
4.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Overview by Application (2018-2034)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size Review by Application (2018-2024)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2024)
4.3.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2024)
5 North America Sustained Release Ocular Drug Delivery Systems by Country
5.1 North America Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
5.1.1 North America Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2024)
5.1.3 North America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2024)
5.2 North America Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
5.2.1 North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2034)
5.2.2 North America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2034)
6 Europe Sustained Release Ocular Drug Delivery Systems by Country
6.1 Europe Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
6.1.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2024)
6.1.3 Europe Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2024)
6.2 Europe Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
6.2.1 Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2034)
6.2.2 Europe Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2034)
7 Asia-Pacific Sustained Release Ocular Drug Delivery Systems by Region
7.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Historic Market Size by Region
7.1.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2024-2034)
8 Latin America Sustained Release Ocular Drug Delivery Systems by Country
8.1 Latin America Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
8.1.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2024)
8.1.3 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2024)
8.2 Latin America Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
8.2.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2034)
8.2.2 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2034)
9 Middle East and Africa Sustained Release Ocular Drug Delivery Systems by Country
9.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
9.1.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 pSivida
10.1.1 pSivida Company Information
10.1.2 pSivida Introduction and Business Overview
10.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
10.1.5 pSivida Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Products Offered
10.2.5 Allergan Recent Development
10.3 Icon Bioscience
10.3.1 Icon Bioscience Company Information
10.3.2 Icon Bioscience Introduction and Business Overview
10.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Products Offered
10.3.5 Icon Bioscience Recent Development
10.4 Ocular Therapeutix
10.4.1 Ocular Therapeutix Company Information
10.4.2 Ocular Therapeutix Introduction and Business Overview
10.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Products Offered
10.4.5 Ocular Therapeutix Recent Development
10.5 Neurotech Pharmaceuticals
10.5.1 Neurotech Pharmaceuticals Company Information
10.5.2 Neurotech Pharmaceuticals Introduction and Business Overview
10.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
10.5.5 Neurotech Pharmaceuticals Recent Development
10.6 Santen Pharmaceutical
10.6.1 Santen Pharmaceutical Company Information
10.6.2 Santen Pharmaceutical Introduction and Business Overview
10.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Products Offered
10.6.5 Santen Pharmaceutical Recent Development
10.7 Aciont Inc.
10.7.1 Aciont Inc. Company Information
10.7.2 Aciont Inc. Introduction and Business Overview
10.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Products Offered
10.7.5 Aciont Inc. Recent Development
10.8 Envisia Therapeutics
10.8.1 Envisia Therapeutics Company Information
10.8.2 Envisia Therapeutics Introduction and Business Overview
10.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Products Offered
10.8.5 Envisia Therapeutics Recent Development
10.9 GrayBug
10.9.1 GrayBug Company Information
10.9.2 GrayBug Introduction and Business Overview
10.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Products Offered
10.9.5 GrayBug Recent Development
10.10 Innocore Pharmaceuticals
10.10.1 Innocore Pharmaceuticals Company Information
10.10.2 Innocore Pharmaceuticals Introduction and Business Overview
10.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
10.10.5 Innocore Pharmaceuticals Recent Development
10.11 OHR Pharmaceuticals
10.11.1 OHR Pharmaceuticals Company Information
10.11.2 OHR Pharmaceuticals Introduction and Business Overview
10.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
10.11.5 OHR Pharmaceuticals Recent Development
10.12 PolyActiva
10.12.1 PolyActiva Company Information
10.12.2 PolyActiva Introduction and Business Overview
10.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Products Offered
10.12.5 PolyActiva Recent Development
10.13 TheraKine
10.13.1 TheraKine Company Information
10.13.2 TheraKine Introduction and Business Overview
10.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
10.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Products Offered
10.13.5 TheraKine Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
11.4 Sustained Release Ocular Drug Delivery Systems Market Dynamics
11.4.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
11.4.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
11.4.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
11.4.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sustained Release Ocular Drug Delivery Systems Distributors
12.3 Sustained Release Ocular Drug Delivery Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Liposome
Table 2. Major Company of Microcapsules/Nanocapsules
Table 3. Major Company of Microspheres/Nanosptheres
Table 4. Major Company of Implants
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (US& Million)
Table 9. Global Sustained Release Ocular Drug Delivery Systems Market Share in Value by Type (2018-2024)
Table 10. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type (2024-2034)
Table 15. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Sustained Release Ocular Drug Delivery Systems Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Company (2018-2024)
Table 28. Global Sustained Release Ocular Drug Delivery Systems Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Company (2018-2024)
Table 30. Global Market Sustained Release Ocular Drug Delivery Systems Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Sustained Release Ocular Drug Delivery Systems Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2022)
Table 34. Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
Table 35. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Sustained Release Ocular Drug Delivery Systems Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2018-2024)
Table 42. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2024-2034)
Table 47. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Sustained Release Ocular Drug Delivery Systems Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2018-2024)
Table 53. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2024-2034)
Table 58. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) (K Pcs)
Table 60. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2024)
Table 73. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2034)
Table 109. pSivida Company Information
Table 110. pSivida Introduction and Business Overview
Table 111. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 113. pSivida Recent Development
Table 114. Allergan Company Information
Table 115. Allergan Introduction and Business Overview
Table 116. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Allergan Sustained Release Ocular Drug Delivery Systems Product
Table 118. Allergan Recent Development
Table 119. Icon Bioscience Company Information
Table 120. Icon Bioscience Introduction and Business Overview
Table 121. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
Table 123. Icon Bioscience Recent Development
Table 124. Ocular Therapeutix Company Information
Table 125. Ocular Therapeutix Introduction and Business Overview
Table 126. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
Table 128. Ocular Therapeutix Recent Development
Table 129. Neurotech Pharmaceuticals Company Information
Table 130. Neurotech Pharmaceuticals Introduction and Business Overview
Table 131. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 133. Neurotech Pharmaceuticals Recent Development
Table 134. Santen Pharmaceutical Company Information
Table 135. Santen Pharmaceutical Introduction and Business Overview
Table 136. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
Table 138. Santen Pharmaceutical Recent Development
Table 139. Aciont Inc. Company Information
Table 140. Aciont Inc. Introduction and Business Overview
Table 141. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
Table 143. Aciont Inc. Recent Development
Table 144. Envisia Therapeutics Company Information
Table 145. Envisia Therapeutics Introduction and Business Overview
Table 146. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
Table 148. Envisia Therapeutics Recent Development
Table 149. GrayBug Company Information
Table 150. GrayBug Introduction and Business Overview
Table 151. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. GrayBug Sustained Release Ocular Drug Delivery Systems Product
Table 153. GrayBug Recent Development
Table 154. Innocore Pharmaceuticals Company Information
Table 155. Innocore Pharmaceuticals Introduction and Business Overview
Table 156. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 158. Innocore Pharmaceuticals Recent Development
Table 159. OHR Pharmaceuticals Company Information
Table 160. OHR Pharmaceuticals Introduction and Business Overview
Table 161. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 163. OHR Pharmaceuticals Recent Development
Table 164. PolyActiva Company Information
Table 165. PolyActiva Introduction and Business Overview
Table 166. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 167. PolyActiva Sustained Release Ocular Drug Delivery Systems Product
Table 168. PolyActiva Recent Development
Table 169. TheraKine Company Information
Table 170. TheraKine Introduction and Business Overview
Table 171. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 172. TheraKine Sustained Release Ocular Drug Delivery Systems Product
Table 173. TheraKine Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Sustained Release Ocular Drug Delivery Systems Market Trends
Table 177. Sustained Release Ocular Drug Delivery Systems Market Drivers
Table 178. Sustained Release Ocular Drug Delivery Systems Market Challenges
Table 179. Sustained Release Ocular Drug Delivery Systems Market Restraints
Table 180. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 181. Sustained Release Ocular Drug Delivery Systems Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Product Picture
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Sustained Release Ocular Drug Delivery Systems Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Liposome
Figure 6. Global Liposome Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Microcapsules/Nanocapsules
Figure 8. Global Microcapsules/Nanocapsules Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Microspheres/Nanosptheres
Figure 10. Global Microspheres/Nanosptheres Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Implants
Figure 12. Global Implants Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2022 & 2034
Figure 15. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type in 2022
Figure 16. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type in 2022
Figure 17. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type in 2022
Figure 18. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type in 2022
Figure 21. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Sustained Release Ocular Drug Delivery Systems Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Sustained Release Ocular Drug Delivery Systems Revenue in 2022
Figure 27. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Cataract
Figure 29. Global Cataract Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Glaucoma
Figure 31. Global Glaucoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Corneal Transplantation
Figure 33. Global Corneal Transplantation Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2022 & 2034
Figure 38. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application in 2022
Figure 39. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application in 2022
Figure 40. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application in 2022
Figure 41. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application in 2022
Figure 44. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Structure
Figure 49. Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries